Market status, market share, growth rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels, and distributors are studied and analysed well with the Porter's Five Forces analysis in this Flow Cytometry market
report. This market report takes into consideration several industry research, customer insights, market sizing forecast, competitive analysis, market entry strategy, pricing trends, sustainability trends, innovation trends, technology evolution, and distribution channel assessment. The report encompasses the top players along with their share by volume in key regions such as APAC, EMEA, and Americas and the challenges faced by them.
The global flow cytometry market is expected to gain market growth in the forecast period of 2022 to 2029. Data Bridge Market Research analyses that the market is growing with a CAGR of 11.2% in the forecast period of 2022 to 2029 and is expected to reach USD 11,016.73 million by 2029 from USD 4,741.84 million in 2021.
Flow cytometry is a key process for screening cells from a heterologous cell mixture used in cell sorting, counting, protein regeneration, and engineering. The analysis of cell surface and intracellular molecule expression, the characterization and definition of various cell types in a heterogeneous cell population, the evaluation of the purity of isolated subpopulations, and the measurement of cell size and volume are all common uses for flow cytometry. It enables the simultaneous examination of multiple parameters for a single cell. A flow cytometer uses lasers to produce light, which is subsequently dispersed by the sample's cells, recorded by detectors, and converted into signals for analysis and measurement.
The increasing innovations and technologies and rising number of players in the market, and novel product launches are also propelling the growth of the global flow cytometry market.
Sysmex Corporation, Agilent Technologies, Inc., BD, Bio-Rad Laboratories, Inc., Beckman Coulter, Inc., Luminex Corporation (now subsidiary of DiaSorin S.p.A.), Sony Biotechnology Inc., Apogee Flow Systems Ltd., Cytek Biosciences, bioMérieux SA, Merck KGaA, Elabscience Biotechnology Inc., Miltenyi Biotec, Takara Bio Inc., Thermo Fisher Scientific Inc., Q2 Solutions (a subsidiary of IQVIA)., CellKraft Biotech Pvt. Ltd., Sartorius AG, NeoGenomics Laboratories, Bay bioscience Co., Ltd., Cell Signaling Technology, Inc., CytoBuoy b.v., ORFLO Technologies, IKEDA SCIENTIFIC Co., Ltd., BioLegend, Inc., II-VI Incorporated, Enzo Biochem Inc., Union Biometrica, Inc., Cytonome/ST, LLC, Stratedigm, Inc, NanoCellect Biomedical, BennuBio Inc., Nexcelom Bioscience LLC, On-chip Biotechnologies Co., Ltd. Corporation, Enzo Biochem Inc., among others.
These increasing prevalence and incidences of chronic diseases are likely to drive market growth by focusing on cytometry devices. The increasing incidences of diseases lead to an increase in the global market as many companies are investing in research and development. This resulted in the enormous lead in demand for advancements to diagnose the disease through quick and accurate techniques.
In January 2021, according to a World Health Organization report, cancer became the major cause of death in 2020, with 10 million in approximation, where often cases were of breast cancer (2.26 million), lung (2.21 million), colon and rectum (1.93 million); prostate (1.41 million), skin (1.20 million) and stomach (1.09 million)
Therefore, this is raising the demand for the flow cytometry market.
Technological developments in cytometry instruments are rising by combining several new techniques to provide high resolution and sensitivity to quantify new entities of cells.
The immunophenotypic analysis is important not only for the initial diagnosis and categorization of acute leukemia, chronic lymphoproliferative disorders, and malignant lymphomas but also for their treatment. Flow cytometry can be used as a sensitive assay to track patients' improvement after chemotherapy or transplantation and detect minimal residual illness (MRD).
In January 2022, Becton, Dickinson and Company, a global medical technology company, announced that a study conducted in collaboration with the European Molecular Biology Laboratory (EMBL) and published the new BD innovation in flow cytometry that adds fluorescence imaging and image-based deaccessioning to sort individual cells at exceptionally high speed, based on the visual details of each cell rather than the type or quantity of biomarkers present. The novel method has the potential to revolutionize immunology, cell biology, and genomics research, as well as enable the development of new cell-based therapeutics
Highlights of TOC:
Chapter 1: Market overview
Chapter 2: Global Flow Cytometry Market
Chapter 3: Regional analysis of the Global Flow Cytometry Market industry
Chapter 4: Flow Cytometry Market segmentation based on types and applications
Chapter 5: Revenue analysis based on types and applications
Chapter 6: Market share
Chapter 7: Competitive Landscape
Chapter 8: Drivers, Restraints, Challenges, and Opportunities
Chapter 9: Gross Margin and Price Analysis
Browse Trending Reports link
About Data Bridge Market Research:
An absolute way to predict what the future holds is to understand the current trend! Data Bridge Market Research presented itself as an unconventional and neoteric market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are committed to uncovering the best market opportunities and nurturing effective information for your business to thrive in the marketplace. Data Bridge strives to provide appropriate solutions to complex business challenges and initiates an effortless decision-making process. Data Bridge is a set of pure wisdom and experience that was formulated and framed in 2015 in Pune.
Data Bridge Market Research has more than 500 analysts working in different industries. We have served more than 40% of the Fortune 500 companies globally and have a network of more than 5,000 clients worldwide. Data Bridge is an expert in creating satisfied customers who trust our services and trust our hard work with certainty. We are pleased with our glorious 99.9% customer satisfaction rating.
Contact Us: -
Data Bridge Market Research
US: +1 888 387 2818
United Kingdom: +44 208 089 1725
Hong Kong: +852 8192 7475